{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:07:44Z","timestamp":1795108064936,"version":"4.10.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["Code: QML20181101"],"award-info":[{"award-number":["Code: QML20181101"]}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["Code: PX2017042, PX2021046"],"award-info":[{"award-number":["Code: PX2017042, PX2021046"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81972562"],"award-info":[{"award-number":["No. 81972562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1245\/s10434-022-11670-6","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T23:03:32Z","timestamp":1649545412000},"page":"5221-5234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["An Evidence-Based Staging System for Mucosal Melanoma: A Proposal"],"prefix":"10.1245","volume":"29","author":[{"given":"ChuanLiang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoShi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiHong","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiNan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiLi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XieQiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SiMing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BiXia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Gershenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"11670_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th edn. New York: Springer; 2017.","edition":"8"},{"key":"11670_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472\u201392.","journal-title":"CA Cancer J Clin"},{"key":"11670_CR3","volume-title":"Melanoma prognosis and staging","author":"EZ Keung","year":"2020","unstructured":"Keung EZ, Balch CM, Thompson JF, et al. Melanoma prognosis and staging. 6th edn. Cham: Springer; 2020.","edition":"6"},{"issue":"4","key":"11670_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(4):399\u2013413.","journal-title":"J Clin Oncol"},{"key":"11670_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/annonc\/mdw694","volume":"28","author":"B Lian","year":"2017","unstructured":"Lian B, Cui CL, Zhou L, et al. The natural history and patterns of metastasis from mucosal melanoma: an analysis of 706 prospectively followed patients. Ann Oncol. 2017;28:868\u201373.","journal-title":"Ann Oncol"},{"issue":"8","key":"11670_CR6","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1245\/s10434-018-6503-9","volume":"25","author":"C Cui","year":"2018","unstructured":"Cui C, Bin L, Li Z, et al. Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients. Ann Surg Oncol. 2018;25(8):2184\u201392.","journal-title":"Ann Surg Oncol"},{"key":"11670_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression model and life tables. J R Stat Soc B. 1972;34:187.","journal-title":"J R Stat Soc B"},{"issue":"81","key":"11670_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejca.2017.05.014","volume":"7","author":"MV Heppt","year":"2017","unstructured":"Heppt MV, Roesch A, Weide B, et al. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer. 2017;7(81):36\u201344.","journal-title":"Eur J Cancer"},{"issue":"36","key":"11670_CR9","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"11670_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.oraloncology.2018.10.022","volume":"87","author":"Y Wu","year":"2018","unstructured":"Wu Y, Wang L, Ma X, et al. The existence of early stage oral mucosal melanoma: a 10-year retrospective analysis of 170 patients in a single institute. Oral Oncol. 2018;87:70\u20136.","journal-title":"Oral Oncol"},{"issue":"8","key":"11670_CR11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664\u201378.","journal-title":"Cancer"},{"issue":"1","key":"11670_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2018.09.054","volume":"81","author":"L Altieri","year":"2019","unstructured":"Altieri L, Eguchi M, Peng DH. Predictors of mucosal melanoma survival in a population-based setting. J Am Acad Dermatol. 2019;81(1):136\u201342.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"11670_CR13","doi-asserted-by":"publisher","first-page":"e112535","DOI":"10.1371\/journal.pone.0112535","volume":"9","author":"T Mehra","year":"2014","unstructured":"Mehra T, Grozinger G, Mann S, et al. Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma. PLoS One. 2014;9(11):e112535.","journal-title":"PLoS One"},{"issue":"3","key":"11670_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ygyno.2011.04.007","volume":"122","author":"KM Moxley","year":"2011","unstructured":"Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol. 2011;122(3):612\u20137.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"11670_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41379-019-0340-7","volume":"33","author":"P Nagarajan","year":"2020","unstructured":"Nagarajan P, Piao J, Ning J, et al. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020;33(3):496\u2013513.","journal-title":"Mod Pathol"},{"issue":"6","key":"11670_CR16","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-014-4215-3","volume":"22","author":"S Seifried","year":"2015","unstructured":"Seifried S, Haydu LE, Quinn MJ, et al. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases. Ann Surg Oncol. 2015;22(6):1959\u201366.","journal-title":"Ann Surg Oncol"},{"key":"11670_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjd.13171","volume":"172","author":"H Eriksson","year":"2015","unstructured":"Eriksson H, Frohm-Nilsson M, Jaras J, et al. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study. Br J Dermatol. 2015;172:175\u201386.","journal-title":"Br J Dermatol"},{"key":"11670_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bjd.12095","volume":"168","author":"J Lyth","year":"2013","unstructured":"Lyth J, Hansson J, Ingvar C, et al. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark\u2019s level of invasion: results of a population-based study from the Swedish Melanoma Register. Br J Dermatol. 2013;168:779\u201386.","journal-title":"Br J Dermatol"},{"issue":"14","key":"11670_CR19","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micro metastases versus macro metastases. J Clin Oncol. 2010;28(14):2452\u20139.","journal-title":"J Clin Oncol"},{"key":"11670_CR20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/AOG.0b013e3181fb8045","volume":"116","author":"M Frumovitz","year":"2010","unstructured":"Frumovitz M, Etchepareborda M, Sun CC, et al. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010;116:1358\u201365.","journal-title":"Obstet Gynecol"},{"key":"11670_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.AOG.0000271209.67461.91","volume":"110","author":"VE Sugiyama","year":"2007","unstructured":"Sugiyama VE, Chan JK, Shin JY, et al. Vulvar melanoma: a multi-variable analysis of 644 patients. Obstet Gynecol. 2007;110:296\u2013301.","journal-title":"Obstet Gynecol"},{"key":"11670_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1245\/s10434-009-0705-0","volume":"17","author":"DM Iddings","year":"2010","unstructured":"Iddings DM, Fleisig AJ, Chen SL, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17:40\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"11670_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/jso.23445","volume":"108","author":"DS Keller","year":"2013","unstructured":"Keller DS, Thomay AA, Gaughan J, et al. Outcomes in patients with mucosal melanomas. J Surg Oncol. 2013;108(8):516\u201320.","journal-title":"J Surg Oncol"},{"key":"11670_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16306","author":"E Sarac","year":"2020","unstructured":"Sarac E, Amaral T, Keim U, et al. Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry. J Eur Acad Dermatol Venereol. 2020. https:\/\/doi.org\/10.1111\/jdv.16306.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"11670_CR25","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and Beyond. Ann Surg Oncol. 2018;25(8):2105\u201310.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11670-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T21:59:01Z","timestamp":1726955941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11670-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11670"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11670-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Jun Guo is the member of the advisory board\/consultant of MSD, Roche, Pfizer, Bayer, Novartis, Simcere, Shanghai Junshi Bioscience, and Oriengene. Jeffrey E. Gershenwald has served as a consultant and\/ or on advisory boards for Merck, Novartis, Bristol-Myers Squibb, Regeneron, Syndax, outside of the current work. Xue Bai declares a merit award supported by BMS. All remaining authors have declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}